Navigation Links
Nora Apothecary & Alternative Therapies Announces a Voluntary Multi-State Recall of All Sterile Compounded Products Due to a Lack of Sterility Assurance
Date:4/22/2013

INDIANAPOLIS, April 22, 2013 /PRNewswire/ -- Nora Apothecary & Alternative Therapies today announced a voluntary multi-state recall of all sterile drug products compounded by the pharmacy that have not reached the expiration date listed on the product. The compounded products that are subject to the recall are those products within their expiration date that were compounded and dispensed by the pharmacy on or before Friday, April 19, 2013.  The recall is being initiated due to concerns associated with quality control processes that present a lack of sterility assurance and were observed during a recent FDA inspection.

Patients are at increased risk for serious infections in the event a sterile product is compromised. To date, Nora has received no reports of injury or illness associated with the use of our sterile products. Patient safety is our highest priority and, out of an abundance of caution, we have decided to initiate this voluntary recall to include all sterile products that are within their expiry periods.

The recall includes sterile products that Nora Apothecary & Alternative Therapies supplied to patients and offices of licensed medical professionals.  Specifically, the recall includes approximately 95 dosage units of sterile compounded products that the pharmacy supplied to offices of twelve licensed medical professionals located within Indiana.  Some patients that received products from those medical professionals may be live in states other than Indiana.  The recall also includes approximately 400 prescriptions compounded for patients within Indiana and four other states; four prescriptions for patients in Illinois; and one prescription each for patients in Ohio, Florida and Tennessee.  A list of products is attached. Nora Apothecary & Alternative Therapies will be notifying customers by phone, fax,mail, or personal visits to return the products to the pharmacy.

Consumers or health care providers with questions regarding this recall may contact Nora Apothecary & Alternative Therapies by phone at 800-729-0276 or 317-251-9547 from the hours of 9:30AM- 6:00PM Eastern Daylight Time Monday through Friday, or at the following e-mail address:pharmacist@noraapothecary.com. Patients who have received any product furnished by Nora Apothecary & Alternative Therapies and have concerns should contact their healthcare provider.

Adverse reactions or quality problems experienced with the use of any Nora Apothecary & Alternative Therapies' products may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail, or by fax.

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

Included products:

Bimix Inj.; Chlorhexidine Opth. Sol'n; Cyclosporine Opth. Oint.; Dexamethasone Opth.Sol'n; EDTA Opth. Sol'n; Folic Acid Inj.; HCG Inj.; Hydroxycobalamin Inj.; Hydroxyprogesterone Inj.; Idoxuridine Opth. Sol'n; Methylcobalamin Inj.; Papaverine Inj.; PGE-1 Inj.; PHMB Opth. Sol'n; Renacidin Irrigation; Tacrolimus Opth. Sol'n; Trimix Inj.; Vancomycin Opth. Sol'n; Apomorphine 3mg/ml Inj.; Gentamicin 24mg/60ml Irrigation; Methylcobalamin 5mg/ml Inj.; Renacidin Irrigation; Buprenorphine 0.6mg/ml Inj.; Tetracaine 2% Inj.; Hydroxycobalamin 1mg/ml MDV; Glutathione 200mg/ml Inj. SDV; Pyridoxine 100mg/ml Inj. MDV; Calcium Gluconate 5% Inj. SDV; Methylcobalamin 1mg/ml Inj MDV; Glutathione 200mg/ml Inj. SDV; EDTA Disodium 15% SDV; Meperidine 100mg/ml MDV; M.I.C.+B12 Inj; Lidocaine 2% MDV

 


'/>"/>
SOURCE Nora Apothecary & Alternative Therapies
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Quantum Materials Corp selects Austin, Texas for new R&D Labs
2. Frost & Sullivan Company of the Year Award Conferred on Medtech SAS
3. Frost & Sullivan Announces Award Categories for 2013 Malaysia Excellence Awards
4. Bioinformatics Market: Technologies, Patenting Trends & 2017 Forecasts
5. Astellas and Gift of Hope Organ & Tissue Donor Network Join Forces to Raise Awareness of Need for More Organ Donors in Illinois
6. Astellas and Gift of Hope Organ & Tissue Donor Network Join Forces to Raise Awareness of Need for More Organ Donors in Chicago
7. 2013 BRIC Medical Devices Market & CIVETS Medical Equipment Industry Analysis
8. Johnson & Johnson Announces Sale of Elan American Depositary Shares to Elan
9. Sinovac EV71 Vaccine Phase III Top-Line Results Presented at 13th Annual World Vaccine Congress & Expo
10. Frost & Sullivan Confers 2013 South Africa Market Share Leadership Award on Shimadzu Corporation
11. Frost & Sullivan: Growing Reimbursement Challenges Force Hospitals to Reengineer Revenue Cycle Management
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2017)... AVACEN Medical (AVACEN) announced that its CE-Marked ... those with the widespread pain associated with fibromyalgia in ... Essex, England commented, "I had ... no sleep at all, tremendous pain, with every movement ... [the AVACEN 100] enough, how this has and is ...
(Date:9/18/2017)... , Sept. 18, 2017 EpiVax, ... of bioinformatics and immune engineering, today announced ... influenza A (H7N9) vaccine. ... to seasonal influenza and presents a challenge ... prior exposure to be effective. Using state-of-the-art ...
(Date:9/12/2017)... SAN FRANCISCO , Sept. 12, 2017 /PRNewswire/ ... Lifecycle Management Solutions (VLMS), is pleased to announce ... as a member of its Board of Directors ... 2017. ValGenesis VLMS enables life science companies to ... eliminate the use of paper in this process. ...
Breaking Medicine Technology:
(Date:10/13/2017)... New York, NY (PRWEB) , ... October 13, 2017 , ... ... most influential people in business to advocate for action towards gender equality at their ... 18,000 views from around the globe, and reached a social audience of over 3 ...
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and ... explains one of the most popular and least understood books in the Holy Scriptures, ... puzzling descriptions that have baffled scholars for centuries. Many have tossed it off as ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a leader in ... awarded a contract by the Center for Medicare and Medicaid Services (CMS). The ... enterprise use of Agile methodologies in a consistent and high value manner across ...
(Date:10/13/2017)... ... ... “America On The Brink”: the Christian history of the United States and ... of published author, William Nowers. Captain Nowers and his wife, Millie, have six ... years in the Navy. Following his career as a naval aviator and carrier ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... are now treating sleep apnea using cutting-edge Oventus O2Vent technology. As ... serious sleep disorder characterized by frequent cessation in breathing. Oral appliances can offer ...
Breaking Medicine News(10 mins):